ACR 20 | Â | Â | Â |
---|---|---|---|
CRP-only model a (n = 308) | Â | Â | Â |
True/Predicted | NR | R | Accuracy |
NR | 35 | 115 | Specificity = 23% |
R | 16 | 142 | Sensitivity = 90% |
Predictive value | NPV = 68% | PPV = 55% | Â |
Threshold = -0.35 | Â | Â | Â |
Biomarker model a (n = 308) | Â | Â | Â |
True/Predicted | NR | R | Accuracy |
NR | 62 | 88 | Specificity = 41% |
R | 16 | 142 | Sensitivity = 90% |
Predictive value | NPV = 79% | PPV = 61% | Â |
Threshold = -0.35 | Â | Â | Â |
Predictors from biomarker modelb | Weight | Odds ratio | Multivariate P value |
Hyaluronic acid | 0.60 | 1.82 | 0.0001 |
Apolipoprotein C3 | -0.98 | 0.38 | 0.003 |
Rheumatoid factor positive at baseline | -0.91 | 0.4 | 0.014 |
Basic fibroblast growth factor | 0.72 | 2.05 | 0.023 |
Interleukin-16 | 0.83 | 2.29 | 0.031 |
Interleukin-6 serum | 0.21 | 1.23 | 0.049 |
C-reactive protein | 0.17 | 1.19 | 0.062 |
ACR 50 | Â | Â | Â |
CRP-only model a (n = 308) | Â | Â | Â |
True/Predicted | NR | R | Accuracy |
NR | 108 | 116 | Specificity = 48% |
R | 17 | 67 | Sensitivity = 80% |
Predictive Value | NPV = 86% | PPV = 36% | Â |
Threshold = -1.3 | Â | Â | Â |
Biomarker model a (n = 308) | Â | Â | Â |
True/Predicted | NR | R | Accuracy |
NR | 137 | 87 | Specificity = 61% |
R | 17 | 67 | Sensitivity = 80% |
Predictive value | NPV = 89% | PPV = 44% | Â |
Threshold = -1.2 | Â | Â | Â |
Predictors from biomarker modelb | Weight | Odds ratio | Multivariate P value |
Hyaluronic acid | 0.53 | 1.70 | 0.001 |
Haptoglobin | 0.79 | 2.2 | 0.001 |
Apolipoprotein C3 | -0.94 | 0.39 | 0.007 |
Interleukin-16 | 1 | 2.72 | 0.014 |
STJC at baseline | 0.17 | 1.19 | 0.015 |
Anti-CCP antibodies | -0.82 | 0.44 | 0.044 |